- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04986059
Effects of Pre-event Massage on Muscle Activity
July 22, 2021 updated by: Albert Pérez Bellmunt, Universitat Internacional de Catalunya
Effects of Pre-event Massage on Muscle Activity During Jump Activities on Gastrocnemius and Hamstring Muscles
The study observes the effect of a pre-event massage on the gastrocnemius and Hamstring muscles on muscle activity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sant Cugat
-
Barcelona, Sant Cugat, Spain, 08195
- Recruiting
- Universitat Internacional Catalunya
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
-
Exclusion Criteria:
- Muscle injury in the last two months
- Suffer a musculoskeletal disorder that doesn't allow the subject to do the study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control
|
|
|
EXPERIMENTAL: Pre-event massage
|
Five minutes massage, combining superficial and high-frequency techniques of massage applied with the therapist hands on gastrocnemius and hamstring muscles
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle activity (microVolts)
Time Frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention
|
sEMG is a NON-invasive method that measures the electrical activity of the muscle generated by the passage of the nerve impulse, which causes depolarization of the muscle cell membrane during excitation.
Once the muscle is contracted and receives electrical signals, the electrodes pick up these signals and record them on the device application.
|
Change between baseline(immediately before intervention) and post intervention (immediately after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Jump Force (Newtons)
Time Frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention)
|
Jump Force will be measured using the Myjump app
|
Change between baseline(immediately before intervention) and post intervention (immediately after intervention)
|
|
Jump speed (m/s)
Time Frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention)
|
Jump Speed will be measured using the Myjump app
|
Change between baseline(immediately before intervention) and post intervention (immediately after intervention)
|
|
Jump Height (cm)
Time Frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention)
|
Jump Height will be measured using the Myjump app
|
Change between baseline(immediately before intervention) and post intervention (immediately after intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
October 1, 2021
Primary Completion (ANTICIPATED)
March 1, 2022
Study Completion (ANTICIPATED)
April 1, 2022
Study Registration Dates
First Submitted
July 22, 2021
First Submitted That Met QC Criteria
July 22, 2021
First Posted (ACTUAL)
August 2, 2021
Study Record Updates
Last Update Posted (ACTUAL)
August 2, 2021
Last Update Submitted That Met QC Criteria
July 22, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Protocol 4B
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Diseases
-
Brugmann University HospitalCompletedAnesthesia, General | Neuromuscular Transmission DisordersBelgium
-
Virginia Commonwealth UniversityRecruitingNeuromuscular Diseases | Neuromuscular Disorder | Neuromuscular Diseases in ChildrenUnited States
-
University Hospital, ToursCompletedNeuromuscular Diseases in Children | Neuromuscular Diseases in InfantsFrance
-
Northwestern UniversityRecruiting
-
Ankara City Hospital BilkentNot yet recruitingNeuromuscular Blockade | Neuromuscular Monitoring | Statin-Associated Myopathy
-
National Institute of Nursing Research (NINR)TerminatedNeuromuscular DiseaseUnited States
-
Landon Pediatric FoundationCompleted
-
Institut de Myologie, FranceCompleted
-
MarsiBionicsHospital Universitario La PazNot yet recruitingNeuromuscular DisordersSpain
Clinical Trials on Pre-event massage
-
Universitat Internacional de CatalunyaUnknown
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedBleeding | Venous Thromboembolism | Chemotherapy Effect | Esophagus CancerNetherlands
-
State University of New York at BuffaloCompletedTrauma | Electronic Health RecordUnited States
-
Philip Morris Products S.A.Completed
-
ANRS, Emerging Infectious DiseasesKappa Santé; CerballianceCompleted
-
Consorci Sanitari de l'Alt Penedès i GarrafCompletedPeripheral Arterial Disease | Atherosclerosis | Acute Coronary Syndrome | Ischemic Heart Disease | Stroke, IschemicSpain
-
University Hospital, CaenUniversity Hospital, ToursActive, not recruitingCancer | Atrial Fibrillation | Bleeding | ThromboembolismFrance
-
NHS Education for ScotlandRecruitingPatient SafetyUnited Kingdom
-
University of AarhusAarhus University HospitalCompleted